Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2022 - A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma

Date

11 Sep 2017

Session

Poster display session

Topics

Cancers in Adolescents and Young Adults (AYA);  Translational Research;  Pancreatic Cancer

Presenters

Davide Melisi

Citation

Annals of Oncology (2017) 28 (suppl_5): v22-v42. 10.1093/annonc/mdx363

Authors

D. Melisi1, G. Piro1, F. Simionato2, C. Carbone1, M. Frizziero2, G. Malleo3, S. Zanini2, R. Casolino2, R. Santoro1, M.M. Mina1, C. Zecchetto2, V. Merz2, A. Scarpa3, C. Bassi3, G. Tortora1

Author affiliations

  • 1 Medicine, University of Verona, 37134 - Verona/IT
  • 2 Unit Of Oncology, Azienda Ospedaliera Universitaria Integrata Verona, 37134 - Verona/IT
  • 3 Unit Of General And Pancreatic Surgery, Azienda Ospedaliera Universitaria Integrata Verona, 37134 - Verona/IT
More

Resources

Abstract 2022

Background

Surgery is the only potentially curative option for patients with pancreatic ductal adenocarcinoma (PDAC), but metastatic relapse remains common. We hypothesized that the expression levels of inflammatory cytokines could predict recurrence of PDAC, thus allowing to select patients who most likely could benefit from surgical resection.

Methods

We prospectively collected plasma at diagnosis from two-hundred eighty-seven patients with pancreatic resectable neoplasms. The expression levels of 23 cytokines were measured in ninety patients with PDAC by using a multiplex analyte profiling assay.

Results

Levels higher than cutoff identified of the TH2 cytokines interleukin (IL)4, IL5, IL6, of macrophage inflammatory protein (MIP)1a, granulocyte-macrophage colony-stimulating factor (GM-CSF), and monocyte chemoattractant protein (MCP)1, and of IL17a, IFN-γ- induced protein (IP)10, and IL1b were significantly associated with a shorter median OS. In particular, levels of IL4 and IP10 higher than cutoff identified, and level of TH1 cytokines TNFa and INFg, and of IL9 and IL1Ra lower than cutoff identified were significantly associated with a shorter DFS. In the multivariate analysis, high IP10 was confirmed as negatively associated with OS (HR = 3.097, P=0.014) and IL4 and TNFa remain negatively (HR = 2.75, P=0.002) and positively (HR = 0.224, P=0.049) associated with DFS, respectively. Simultaneous expression of low IL4 and high TNFa identified patients with best prognosis (HR = 0.313, P

Conclusions

We demonstrated that, among a series of cytokines, IL4 is the most significant independent prognostic factor for DFS in resectable PDAC patients, and it could be useful to select patients with high risk of early recurrence who may avoid an unnecessary resection.

Clinical trial identification

Legal entity responsible for the study

University of Verona

Funding

Associazione Italiana per la Ricerca sul Cancro (AIRC)

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.